← Every applicant
Gilead Sciences Inc FDA Approvals
9 new drug approvals and 0 device clearances on file. Matched by name to GILD.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| BIXLENVONew drugAug 27, 2026TABLET, ORAL |
| BIXLENVO SUNLENCA STARTER PACK (COPACKAGED)New drugAug 27, 2026TABLET, ORAL |
| HEPCLUDEXNew drugMay 22, 2026INJECTION, POWDER,FOR SOLUTION |
| YEZTUGONew drugJun 18, 2025TABLET, ORAL |
| YEZTUGONew drugJun 18, 2025SOLUTION, SUBCUTANEOUS |
| LIVDELZINew drugAug 14, 2024CAPSULE, ORAL |
| SUNLENCANew drugDec 22, 2022TABLET, ORAL |
| SUNLENCANew drugDec 22, 2022SOLUTION, SUBCUTANEOUS |
| EPCLUSANew drugJun 10, 2021PELLETS, ORAL |